Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Monopar Therapeutics Inc.”

3 pharma patents match "Monopar Therapeutics Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Monopar Therapeutics Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Monopar Therapeutics Inc.” · 30,257 patents in full index Clear search

  1. US 11090290

    Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

    Monopar Therapeutics Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  2. US 10675271

    Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

    Monopar Therapeutics Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  3. US 10450340

    3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation

    Monopar Therapeutics Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted